Medicare Enrolled
Dr. Juan Jimenez, M.D., PH.D.
Urology Physician · Cleveland, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Jimenez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jimenez?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Jimenez
Dr. Juan Jimenez is an urology physician in Cleveland, OH, with 16 years of NPI registration. Based on federal Medicare data, Dr. Jimenez performed 1,372 Medicare services across 1,131 unique beneficiaries.
Between the years covered by Open Payments, Dr. Jimenez received a total of $32,381 from 48 pharmaceutical and/or device companies across 362 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jimenez is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 37% volume in OH
$32,381 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,372
Medicare services
Top 37% in OH for urology physician
1,131
Unique beneficiaries
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~86 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
344 | $56 | $148 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
319 | $2 | $12 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
109 | $82 | $298 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
89 | $93 | $602 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
63 | $98 | $406 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
52 | $6 | $47 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
51 | $39 | $108 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
40 | $16 | $41 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
37 | $102 | $482 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
29 | $65 | $289 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
25 | $5 | $213 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
24 | $174 | $865 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
19 | $85 | $810 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
19 | $162 | $887 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
19 | $132 | $470 |
| Electronic analysis of implanted neurostimulator This procedure involves electronically analyzing an implanted neurostimulator generator and performing simple programming for spinal cord or peripheral nerve stimulation. |
18 | $35 | $122 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
17 | $312 | $2,129 |
| Injection, garamycin, gentamicin, up to 80 mg | 17 | $2 | $2 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
15 | $86 | $582 |
| Electronic analysis of implanted neurostimulator Electronic evaluation of an implanted brain, spinal cord, or peripheral nerve stimulator device. |
15 | $15 | $71 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $34 | $100 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
13 | $40 | $314 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
12 | $22 | $506 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
11 | $66 | $722 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.7% high complexity
6.0% medium
90.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$32,381
Total received (2018-2024)
Avg $4,626/year across 7 years
Top 7% in OH for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
362
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$24,204 (74.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,839 (24.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$338 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$836
2023
$885
2022
$1,344
2021
$1,591
2020
$6,959
2019
$18,716
2018
$2,048
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$250
PROCEPT BioRobotics Corporation
$235
Boston Scientific Corporation
$231
Tolmar, Inc.
$53
Endo USA, Inc.
$26
Olympus America Inc.
$25
Bayer Healthcare Pharmaceuticals Inc.
$16
Top 3 companies account for 85.6% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$23,700
Medtronic, Inc.
$1,990
Medtronic USA, Inc.
$1,615
BOSTON SCIENTIFIC CORPORATION
$1,329
Astellas Pharma US Inc
$674
NxThera, Inc.
$338
CONMED Corporation
$324
Endo Pharmaceuticals Inc.
$316
PROCEPT BioRobotics Corporation
$235
Axonics Modulation Technologies, Inc.
$172
Janssen Biotech, Inc.
$147
TOLMAR Pharmaceuticals, Inc.
$147
Dendreon Pharmaceuticals LLC
$113
PFIZER INC.
$107
SANOFI-AVENTIS U.S. LLC
$99
Blue Earth Diagnostics Limited
$98
Antares Pharma, Inc.
$96
Tolmar, Inc.
$90
UroGen Pharma, Inc.
$68
Bayer HealthCare Pharmaceuticals Inc.
$65
UROGEN PHARMA, INC.
$58
Amgen Inc.
$39
MEDIVATION FIELD SOLUTIONS LLC
$36
Bayer Healthcare Pharmaceuticals Inc.
$36
AbbVie Inc.
$34
Richard Wolf Medical Instruments Corp.
$31
Allergan, Inc.
$30
Merck Sharp & Dohme LLC
$29
Sun Pharmaceutical Industries Inc.
$29
Endo USA, Inc.
$26
Seagen Inc.
$26
GENZYME CORPORATION
$25
Olympus America Inc.
$25
Baxter Healthcare
$22
ConvaTec Inc.
$22
DENTSPLY IH Inc.
$19
PRN Medical Services, LLC
$18
Medtronic Vascular, Inc.
$17
Myovant Sciences Inc.
$17
Dornier MedTech America, Inc
$16
Progenics Pharmaceuticals, Inc.
$16
CooperSurgical, Inc.
$15
Mission Pharmacal Company
$15
Laborie Medical Technologies Corp.
$14
Ferring Pharmaceuticals Inc.
$13
ACELL, INC.
$13
Janssen Pharmaceuticals, Inc
$12
Clarus Therapeutics Inc.
$7
Top 3 companies account for 84.3% of all-time payments
Associated products mentioned in payments ›
AIRSEAL · AMS · AMS 700 · AQUABEAM SYSTEM · AVEED · Aquoral · Axonics r-SNM System · Axumin · BOTOX · ELIGARD · ERLEADA · Erleada · FIRMAGON · FLEXIVA · GENERAL BPH · GENERAL BPH · GENERAL ERECTILE DYSFUNCTION · GENERAL PELVIC ORGAN PROLAPSE · GENERAL THERAPIES · GENERAL - BPH · GENERAL BPH · GENERAL ERECTILE DYSFUNCTION · GENERAL KIDNEY STONE DISEASE · GENTLECATH · GENTLECATH GLIDE · GREENLIGHT · INTERSTIM · JATENZO · JELMYTO · JEVTANA · KEYTRUDA · LITHOVUE · LUPRON DEPOT · Lithotripters & Accessories · LoFric · MYRBETRIQ · Myrbetriq · NOCDURNA · Nubeqa · ORGOVYX · PADCEV · PROVENGE · PYLARIFY · REZUM · Rezum · SWISS LITHOCLAST TRILOGY · SeeClear XcL Laparoscopic Smoke Evacuation System · TISSEEL · TRIA · TYRX · VESICARE · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (75%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for urology physician in OH.
Geographic Context
Urology physicians within 10 mi
69
Per 100K population
5.5
County median income
$62,823
Nearest hospital
FAIRVIEW HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Jimenez is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 7% of OH peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Jimenez experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Jimenez performed 344 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jimenez receive payments from pharmaceutical companies?
Yes. Dr. Jimenez received a total of $32,381 from 48 companies across 362 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jimenez's costs compare to other urology physicians in Cleveland?
Dr. Jimenez's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jimenez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Cleveland
Browse urology physicians in Cleveland ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in OH
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in OH
Which OH urology physicians receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology